Literature DB >> 18090081

Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation.

Takashi Nakajima1, Haku Iizuka, Shinichi Tsutsumi, Masatomo Kayakabe, Kenji Takagishi.   

Abstract

STUDY
DESIGN: An animal study to achieve posterolateral intertransverse process spine fusion using mesenchymal stem cell (MSC).
OBJECTIVE: We investigated the effectiveness of graft material for spinal fusion using a rabbit model by examining the MSC with or without osteogenic differentiation. SUMMARY OF BACKGROUND DATA: Posterolateral spinal fusion is commonly performed. Autogenous bone graft is the gold standard, although various problems are reported. Recently, MSCs from bone marrow have been studied in various fields. Thus, we supposed that MSCs have the ability to spinal fusion.
METHODS: Twenty-four mature male Japanese white rabbits (weight, 3.0-4.0 kg) were divided into 4 groups: 1) autologous bone (AG), 2) hydroxyapatite (HA), 3) MSC, and 4) osteogenic MSC (OMSC). Each group underwent fusion of the intertransverse processes. The lumbar spine was harvested en bloc, and the fusion mass was evaluated radiographically, by manual palpation test, and by histologic analysis at 6 weeks after surgery.
RESULTS: Fusion success or failure was assumed based on the results from manual palpation of the harvested spine. Four of 5 rabbits in the OMSC group, 4 of 6 rabbits in the AB group, 2 of 6 rabbits in the MSC group, and none of 6 rabbits in the HA group achieved fusion. In the OMSC group and AG group, new bone formation was observed histologically. In the HA group, fibrous tissue and cartilage were observed and there was no new bone. In the MSC group, less mature bone formation was present in the grafted fragments.
CONCLUSION: The present study suggested that MSCs that have been cultured with osteogenic differentiation medium may induce the formation of new bone in experimental spinal fusion. Further studies are needed to determine the suitable level of osteogenic differentiate of MSC as well as the most appropriate carrier for MSC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18090081     DOI: 10.1097/BRS.0b013e3181573924

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  23 in total

Review 1.  Stem cells for spine surgery.

Authors:  Joshua Schroeder; Janina Kueper; Kaplan Leon; Meir Liebergall
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

2.  The combination of mesenchymal stem cells and a bone scaffold in the treatment of vertebral body defects.

Authors:  Václav Vaněček; Karel Klíma; Aleš Kohout; René Foltán; Ondřej Jiroušek; Jiří Šedý; Jan Štulík; Eva Syková; Pavla Jendelová
Journal:  Eur Spine J       Date:  2013-09-07       Impact factor: 3.134

3.  Genetically modified mesenchymal stem cells induce mechanically stable posterior spine fusion.

Authors:  Dima Sheyn; Martin Rüthemann; Olga Mizrahi; Ilan Kallai; Yoram Zilberman; Wafa Tawackoli; Linda E A Kanim; Li Zhao; Hyun Bae; Gadi Pelled; Jess G Snedeker; Dan Gazit
Journal:  Tissue Eng Part A       Date:  2010-09-28       Impact factor: 3.845

4.  An allograft generated from adult stem cells and their secreted products efficiently fuses vertebrae in immunocompromised athymic rats and inhibits local immune responses.

Authors:  Bret H Clough; Eoin P McNeill; Daniel Palmer; Ulf Krause; Thomas J Bartosh; Christopher D Chaput; Carl A Gregory
Journal:  Spine J       Date:  2016-10-17       Impact factor: 4.166

5.  Differentiation Potential of Human Chorion-Derived Mesenchymal Stem Cells into Motor Neuron-Like Cells in Two- and Three-Dimensional Culture Systems.

Authors:  Faezeh Faghihi; Esmaeil Mirzaei; Jafar Ai; Abolfazl Lotfi; Forough Azam Sayahpour; Somayeh Ebrahimi Barough; Mohammad Taghi Joghataei
Journal:  Mol Neurobiol       Date:  2015-03-20       Impact factor: 5.590

6.  The effectiveness of bone mineral density as supplementary tool for evaluation of the osteogenic potential in patients with spinal fusion.

Authors:  Byung-Hak Kim; Heun-Guyn Jung; Kyung-Ho Park; Dae-Hee Kim; Yong-Soo Choi
Journal:  Asian Spine J       Date:  2009-06-30

7.  Effect of hyperbaric oxygen on mesenchymal stem cells for lumbar fusion in vivo.

Authors:  Tsai-Sheng Fu; Steve W N Ueng; Tsung-Ting Tsai; Lih-Huei Chen; Song-Shu Lin; Wen-Jer Chen
Journal:  BMC Musculoskelet Disord       Date:  2010-03-19       Impact factor: 2.362

8.  Fast degradable citrate-based bone scaffold promotes spinal fusion.

Authors:  Jiajun Tang; Jinshan Guo; Zhen Li; Cheng Yang; Denghui Xie; Jian Chen; Shengfa Li; Shaolin Li; Gloria B Kim; Xiaochun Bai; Zhongmin Zhang; Jian Yang
Journal:  J Mater Chem B       Date:  2015-07-21       Impact factor: 6.331

9.  Evaluation of Spinal Fusion Using Bone Marrow Derived Mesenchymal Stem Cells with or without Fibroblast Growth Factor-4.

Authors:  Hyun Sung Seo; Jong Kwon Jung; Mi-Hyun Lim; Dong Keun Hyun; Nam-Sik Oh; Seung Hwan Yoon
Journal:  J Korean Neurosurg Soc       Date:  2009-10-31

Review 10.  Factors influencing arthrodesis rates in a rabbit posterolateral spine model with iliac crest autograft.

Authors:  Jason H Ghodasra; Erika L Daley; Erin L Hsu; Wellington K Hsu
Journal:  Eur Spine J       Date:  2013-10-29       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.